Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
0.9199
-0.0002 (-0.02%)
At close: Apr 24, 2026, 4:00 PM EDT
0.9000
-0.0199 (-2.16%)
After-hours: Apr 24, 2026, 4:00 PM EDT

ZYBT Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-22.8113.4737.5155.7446.47
Depreciation & Amortization
25.1424.1623.9118.816.01
Other Adjustments
1.494.397.049.393.04
Change in Receivables
26.5712.5939.35-47.37-40.68
Changes in Inventories
3.76-5.88-12.9-12.33-12.34
Changes in Accounts Payable
0.62-0.4-35.61-9.6717.63
Changes in Accrued Expenses
4.762.7-0.580.210.52
Changes in Income Taxes Payable
-1.67-0.23-7.73.190.8
Changes in Unearned Revenue
2.03-0.4-0.720.321.4
Changes in Other Operating Activities
-26.26-9.35-2.12-0.94-1.04
Operating Cash Flow
12.3941.0548.1817.3431.81
Operating Cash Flow Growth
-77.45%-14.81%177.96%-45.50%-
Capital Expenditures
-12.08-13.59-7.4-27.33-19.06
Sale of Property, Plant & Equipment
-0.111.06-0.13
Purchases of Intangible Assets
-0.52-14.19-4.2--7.34
Purchases of Investments
---1.22--
Investing Cash Flow
-12.5-27.67-11.77-27.33-26.27
Long-Term Debt Issued
85.1290.1279.8699.8530
Long-Term Debt Repaid
-87.49-92.86-54.89-64.97-22
Net Long-Term Debt Issued (Repaid)
-2.37-2.7424.9734.888
Issuance of Common Stock
44.55----
Net Common Stock Issued (Repurchased)
44.55----
Common Dividends Paid
-0.17-16.02-39.45-21.43-11.05
Other Financing Activities
-3.12-3.37-4.5--
Financing Cash Flow
39.04-22.13-18.9813.46-3.05
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.510.17---
Net Cash Flow
38.25-8.7517.443.462.49
Free Cash Flow
0.3127.4640.79-9.9912.75
Free Cash Flow Growth
-98.89%-32.68%---
FCF Margin
0.20%14.73%19.27%-3.84%5.95%
Free Cash Flow Per Share
0.010.600.89-0.220.28
Levered Free Cash Flow
-25.455.5813.3153.8650.88
Unlevered Free Cash Flow
-26.1612.39-4.5629.6649.79
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q